Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 282 (RN7SKP282) is a pseudogene related to RN7SK, a well-studied small nuclear RNA involved in transcription elongation and immune regulation, especially in macrophage polarization and phagocytosis[2][3]. However, unlike the functional RN7SK transcript, RN7SKP282 is classified as a non-protein-coding RNA pseudogene without validated biological function, disease relevance, or evidence as a direct molecular drug target. All known molecular functions and disease roles relate to the canonical RN7SK, not its pseudogenes. Consequently, RN7SKP282 is not considered a therapeutic target, and many relevant fields (molecular classification, disease roles, drug interactions, biomarkers, safety concerns) should be labeled as null or omitted for this entity[1][2][3]. If you are seeking details for the functional RN7SK molecule itself, refer specifically to "RNA, 7SK small nuclear RNA" (RN7SK), which acts as a long non-coding RNA modulating transcriptional elongation and immune cell function[2][3]. RN7SKP282 shares sequence similarity but lacks the evidence for functional activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 282 (RN7SKP282).